BNGO

BNGO

USD

Bionano Genomics Inc. Common Stock

$3.700+0.030 (0.817%)

Reaalajas hind

Healthcare
Medical Instruments & Supplies
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$3.670

Kõrge

$3.780

Madal

$3.660

Maht

0.05M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

12.4M

Tööstusharu

Medical Instruments & Supplies

Riik

United States

Kauplemisstatistika

Keskmine maht

0.14M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $2.68Praegune $3.700Kõrge $52.2

Seotud uudised

Analyst Upgrades

Maxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target

Maxim Group analyst Jason McCarthy upgrades Bionano Genomics from Hold to Buy and announces $8 price target.

Vaata rohkem
Maxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target
GlobeNewswire

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today reported financial results for the first quarter ended March 31, 2025. "The first quarter of 2025 represents the first full

Vaata rohkem
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress
GlobeNewswire

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 14, 2025, at 4:30 p.m. Eastern Time to report

Vaata rohkem
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025
GlobeNewswire

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome

Vaata rohkem
International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.